Nonmyeloablative and reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation: a clinical review.
about
The role of concomitant extracorporeal photopheresis for the treatment of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantationBone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adultsBone marrow versus peripheral blood allogeneic hematopoietic stem cell transplantation for haematological malignanciesThe role of concomitant extracorporeal photopheresis for the treatment of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantationPolyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adultsAdoptive T-cell therapy for LeukemiaPerivascular, but not parenchymal, cerebral engraftment of donor cells after non-myeloablative bone marrow transplantationCutaneous graft-versus-host disease: rationales and treatment options.Promising role of reduced-toxicity hematopoietic stem cell transplantation (PART-I).Indications and outcomes of reduced-toxicity hematopoietic stem cell transplantation in adult patients with hematological malignancies.Complications of allogeneic hematopoietic stem cell transplantation.Secondary malignancies after allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning and outpatient conduction.Ocular complications in children after hematopoietic stem cell transplantation without total body irradiation.Effects of sublethal irradiation on patterns of engraftment after murine bone marrow transplantationDissecting the mechanisms involved in anti-human T-lymphocyte immunoglobulin (ATG)-induced tolerance in the setting of allogeneic stem cell transplantation - potential implications for graft versus host disease.
P2860
Q24186279-65531256-BD46-495A-A81D-E380D16EA990Q24195048-02415CBC-898B-416A-B8CD-A1A677F616CAQ24197741-4D6C6F18-2B30-4E27-87D6-766563A3E1C8Q24198004-99D60DD9-6D6A-4C51-AEBF-8A337CD0F1BFQ24200813-57392BA2-D7C9-4EC2-909D-22AE947C2F4DQ27006934-FD0C7609-F523-4784-BDCF-354B328B901CQ36997172-B160332C-7003-4185-9143-E601B69071BBQ37853600-900091A7-8CFF-4B6C-9CAE-AF6CA97A8A03Q38029953-86B7A8B5-5131-4648-8AA6-1E028285B83CQ38098957-28F8080C-8033-43F4-AD56-7174262A97FBQ38217938-B3DE1BC7-C63D-4A9B-8A98-1DD5D6ED9DB1Q40217390-B00522FF-7C96-4BDE-AC4F-ACF857AA04B1Q41468116-2B561F9D-0B73-4AF3-BF87-8BBFCADF940BQ42726079-EF6209AF-2D10-43B3-B367-17D13B95EB29Q47161119-03548F6C-BC40-4D0D-BD7E-0DEBBBF4DA8A
P2860
Nonmyeloablative and reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation: a clinical review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nonmyeloablative and reduced-i ...... plantation: a clinical review.
@en
Nonmyeloablative and reduced-i ...... plantation: a clinical review.
@nl
type
label
Nonmyeloablative and reduced-i ...... plantation: a clinical review.
@en
Nonmyeloablative and reduced-i ...... plantation: a clinical review.
@nl
prefLabel
Nonmyeloablative and reduced-i ...... plantation: a clinical review.
@en
Nonmyeloablative and reduced-i ...... plantation: a clinical review.
@nl
P2093
P1476
Nonmyeloablative and reduced-i ...... plantation: a clinical review.
@en
P2093
Imad A Tabbara
Jana Hashash
Seth M Pollack
Thomas P O'Connor
P304
P356
10.1097/COC.0B013E31817F9DE1
P577
2009-12-01T00:00:00Z